GlaxoSmithKline Prepares Cervarix Launch In Japan
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline announced a plan to launch human papillomavirus vaccine Cervarix to prevent cervical cancer in Japan on Dec. 22